Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples